TCT-410 Comparison of Coronary Artery Bypass Surgery, Percutaneous Drug-eluting Stent Implantation, and Medical Therapy for Unprotected Left Main Coronary Artery Disease  by Zyrianov, Igor et al.
TUESDAY, OCTOBER, 29, 2013, 3:30 PM–5:30 PM www.jacctctabstracts2013.com
P
O
S
T
E
R
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increasing complications for severely calciﬁed ULM stenosis. Especially in no HD
patients, excellent results were obtained at 1-year. However, the development of
TLR-MB had still occurred in 38% of the HD patients despite optimal stent
expansion.
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Background: Unprotected left main coronary artery (ULMCA) disease is considered
an indication for revascularization. However, in “real-world” clinical practice some
patients receive medical therapy only. The arm of this study was to evaluate long-term
results in patients with ULMCA disease in a “real-world” practice.
Methods: Between January 2006 and June 2011, 218 stable patients were diagnosed
with de novo ULMCA stenosis. 52 (23.9%) patients received medical therapy only,
coronary artery bypass grafting (CABG) was performed in 106 (48.6%) patients,
percutaneous coronary intervention (PCI) in 60 (27.5%) patients. The composite of
death, myocardial infarction, and stroke deﬁned as major adverse cardiac and cere-
brovascular events (MACCE) and target vessel revascularization (TVR) were deﬁned
as primary endpoints. The median follow-up period was 4 years.
Results: Baseline clinical and descriptive morphology of coronary artery disease
revealed more comorbidities and more complex anatomies in the medical therapy group
compare with CABG and PCI groups. Revascularization might not have been used due
to physician's decision (operative risk considered excessive) in 24 (46.2%) cases or
when patients refused revascularization in 28 (53.8%) cases. At 4-year follow-up
MACCE rate was higher in nonsurgical group (34.6%) compare with CABG (13.2%;
p¼0.002) and PCI (14.5%; p¼0.016) groups, but there was no difference between
CABG and PCI groups. Survival in CABG (4.7%; p<0.001) and PCI (5.5%; p¼0.009)
groups was higher in compare with nonsurgical group (23.1%). On the multivariable
Cox regression analysis, coronary revascularization (CABG and PCI) was independent
predictor of long-term survival (HR 3.49; 95% CI 1.39-8.75; P<0.001).
Conclusions: PCI, like CABG improves survival for patients with unprotected left
main coronary artery disease compared with medical therapy only in “real-world”
clinical practice.
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Background: Clinical outcomes after treatment of true bifurcation lesions (Medina
classiﬁcation: 1.1.1, 1.0.1 and 0.1.1) are in general inferior when compared to non-true
bifurcation lesions (1.1.0, 0.0.1, 0.1.0). Therefore, our aim was to compare clinical
outcomes of the patients with true and non-true bifurcation lesions treated with Nobori
DES. This stent with open cell design and bioresorbable polymer is expected to
perform well in lesions involving bifurcation.
Methods: Within the large, prospective, single-arm, multi-centre, eNOBORI registry,
898 patients (1541 lesions) had at least one bifurcation treated. Bifurcation lesions
(BL) were divided into true (TBL, 512 patients; 927 lesions) and non-true bifurcation
lesions (NTBL, 386 patients; 614 lesions). All adverse events are adjudicated by an
independent clinical event committee. Primary endpoint of the study is target lesion
failure (TLF) at 1 year.
Results: Patients in both groups had similar baseline characteristics, except that patients
with TBL were less often male (74.8% vs 81.6%) and presented more often with renal
failure (8.1% vs 4.7%). Average number of lesions treated per patient and stents
implanted per lesion was higher in TBL than in NTBL (2.461.50 vs 2.151.50;
p< 0.01 and 1.280.55 vs. 1.160.43; p< 0.01, respectively). According to theMedina
classiﬁcation, the most frequent lesion type in TBL was [1.1.1] (66.2%), whereas in
NTBL, [1.1.0] type was most abundant (42.9%). Direct stenting was more frequent in
NTBL (35.9%vs. 22.6%; p<0.01) and procedural successwas similar in TBLandNTBL
groups (98.2% vs 99.2%). In the TBL group, 3 patients died (1.0%; cardiac), 5 patients
had TV-MI (1.7%) and 9 patients a TLR (3.0%) at 12 months, resulting int TLF of 6.0%.
In the NTBL group, 1 patient died (0.5%; cardiac), 2 patients had TV-MI (0.9%) and 4
patients a TLR (1.9%), resulting in a TLF of 3.2%. No stent thrombosis were observed in
the NTBL whereas 2 deﬁnite, subacute ST (0.48%) occurred in TBL patients (p¼ NS).
Conclusions: As expected, clinical outcomes after treatment of true bifurcation
lesions were less favorable compared to the non-true bifurcation lesions however, the
results of both cohorts are very good up to one year.B128 JACC Vol 62/18/Suppl B j October 27–November 1, 2TCT-412
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Background: Long term clinical outcomes after biodegradable polymer eluting stents
implantation at bifurcation lesions are unclear.
Methods:We analyzed 203 consecutive patients (208 bifurcation lesions treated) who
were treated with PCI with biodegradable polymer coating biolimus-eluting
stent(BES) exclusively at our institution between February 2005 and April 2009. They
were followed up prospectively after the PCI (median follow-up 1931 days).
Results: One hundred sixty one patients (79%) were male and mean ages were 69 
10.3. LMT lesions were 63(30%). Eighty lesions(38%) were treated by culotte
stenting technique and other 128 lesions(61%) treated by stenting and kissing balloon
technique(S-KBT). We evaluated the incidence for MACE, which were deﬁned as
a combined end point of cardiac death, MI or TLR. During that period, the rate of
MACE, cardiac death, MI and TLR were 15.8%, 4.3%, 1.0%, 10.0% respectively. The
rate of MACE and TLR were not different between culotte stenting technique and
S-KBT (p¼0.35 and p¼0.29 respectively).
Conclusions: Long term outcome after PCI of bifurcation lesions with biodegradable
polymer coating BES might be promising.TCT-413
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Background: PCI to the left main coronary artery (LMCA) frequently involves the
bifurcation with signiﬁcant rates of repeat revascularisation. Single stent or 2 stent
techniques may be related to the pattern of plaque distribution using the Medina
system.
Methods: 254 patients underwent PCI to the distal LMCA, they were observed for
a combined adverse endpoint (CAE), repeat revascularisation, MI and all-cause
death. We categorised bifurcations into (Medina 1,1,1 and 0,1,1), both branch (BB)
involvement or only a single branch(SB) involvement (all other Medina groups).
Stent technique was categorised as simple (single stent) or complex (any 2 stent
technique).
Results: 161 (63%) patients had BB involvement. Follow-up 2.26 (3.1) years. Median
SYNTAX (IQR) 34.0(17.0) and 25.0(16.0), p<0.000. Median Additive Euro-
SCORE(IQR) was 7(6) and 6(5), p<0.000. Unadjusted CAE rates higher in the BB
group at 30 days (5.6% vs 3.2%, p ¼0.4), 6 months (16.1% vs 7.5%, p ¼ 0.05), 12
months (24.8% vs 12.9%, p ¼ 0.02) and long term (43.5% vs 29.0%, p ¼ 0.02).A
simple stent strategy was used in 59% of patients, 84% of the BB group. CAE rates were
not different between patients treated by simple and complex techniques. After
adjustment, BB disease and untreated severe right coronary artery(RCA) disease were
independently associated with an increase in CAE, adjusted hazard ratios (95% CI) 1.84
(1.24 to 2.72) and 1.80 (1.22 to 2.65).013 j TCT Abstracts/POSTER/Bifurcation and Left Main Interventions
